Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Carrington Laboratories Announces Third Quarter 2003 Conference Call.


Business Editors

IRVING, Texas--(BUSINESS WIRE)--Nov. 10, 2003

Carrington Laboratories, Inc. (Nasdaq: CARN) will hold its quarterly conference call to discuss third quarter earnings results on Thursday, November 13, 2003 at 3:30PM Central, 4:30PM Eastern. Earnings will be released the same day, before market opens.

Investors are invited to listen to the call by dialing 800-901-5226 (toll free) and +617-786-4513 international. This call is also being webcast by CCBN CCBN Central Coast Bancorp
CCBN Charles County Business Network
 and can be accessed at Carrington's web site at www.carringtonlabs.com.

The webcast will be distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors are invited to listen to the call through CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents at www.streetevents.com.

About Carrington Laboratories, Inc.

Carrington Laboratories, Inc., is an ISO (1) See ISO speed.

(2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI.
 9001-certified, research-based biopharmaceutical and consumer products company currently utilizing naturally occurring complex carbohydrates complex carbohydrates,
n.pl polysaccharides; nutritional compounds composed of multiple monosaccharide (simple sugar) building blocks. Complex carbohydrates include starches, glycogen, and cellulose.
 to manufacture and market products for mucositis, radiation dermatitis radiation dermatitis
n.
See radiodermatitis.
, wound and oral care as well as to manufacture and market the nutraceutical raw materials Manapol(R) and Hydrapol(TM). Carrington Laboratories also manufactures and markets consumer products sold under its AloeCeuticals(R) brand and manufactures quality products for other companies. Manufacturing operations Manufacturing operations concern the operation of a facility, as opposed to maintenance, supply and distribution, health, and safety, emergency response, human resources, security, information technology and other infrastructural support organizations.  comply with cGMP standards. The company's DelSite subsidiary is developing its proprietary GelSite(TM) technology designed to provide controlled release of peptide and protein-based drugs. More than 120 patents in 26 countries protect Carrington Laboratories' technology. Select products are honored with the internationally coveted cov·et  
v. cov·et·ed, cov·et·ing, cov·ets

v.tr.
1. To feel blameworthy desire for (that which is another's). See Synonyms at envy.

2. To wish for longingly. See Synonyms at desire.
 CE mark, recognized by more than 20 countries around the world. For more information, visit www.carringtonlabs.com.

Certain statements in this release concerning Carrington Laboratories, Inc. may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to subsequent changes in plans by management, delays or problems in formulation, manufacturing, distribution, production and/or launch of new finished products, supply of raw materials, separation and formulation of GelSite production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission, including Form 10-Q Form 10-Q

See 10-Q.
 filed August 14, 2003.

Carrington, Manapol, AloeCeuticals, Hydrapol, GelSite and Acemannan Hydrogel hy·dro·gel
n.
A colloidal gel in which the particles are dispersed in water.



hydrogel

a gel that contains water.

hydrogel Wound care A polymer absorptive wound dressing. See Dressing.
 are trademarks, registered trademarks or service marks of Carrington Laboratories, Inc., in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and/or other countries. All other trademarks or service marks contained herein are the properties of their respective owners.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 10, 2003
Words:426
Previous Article:IMN Unveils New Tools for Correlating Content to Reader Behaviors, Enabling E-Marketers to Take Quick Action to Improve ROI.
Next Article:Frequency Electronics Announces New Satellite Contract.



Related Articles
Carrington Laboratories Inc. issues third quarter results.
Carrington Laboratories raises $6.6 million in Series E preferred stock issue.
Carrington Laboratories Announces Italian Distribution Agreement With Recordati Pharmaceuticals SpA.
Carrington Laboratories announces expanded Central and South American sales distribution agreement.
Carrington Laboratories Reports Improved Fourth Quarter Wound Care Product Sales.
STARTING OVER; THE MASTER'S JOSH CARRINGTON MOVES FROM CLOSER TO STARTER.
VAN NUYS TEACHER IN RUNNING FOR AWARD.
Carrington Laboratories Sets Fourth Quarter 2003 Earnings Conference Call.
Carrington Laboratories, Inc. First Quarter 2006 Earnings Conference Call.
What you look like online.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles